BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2776057)

  • 1. [Diagnostic value of serum alpha-L-fucosidase in primary hepatic carcinoma].
    Ke JL
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):153-5. PubMed ID: 2776057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
    Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
    Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
    Yu ZW; Duan FL; Yang XW
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
    Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
    Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
    [No Abstract]   [Full Text] [Related]  

  • 7. [The value of serum alpha-L-fucosidase activity in the diagnosis of primary liver cancer].
    Wei X; Wang S; Rui J
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):148-50. PubMed ID: 11776645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
    Wang JJ; Cao EH
    Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
    Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
    Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
    Shi X; Zhou Y; Xia L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
    Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined five tumor markers in detecting primary hepatic carcinoma].
    Ma J; Gong Q; Lin M; Xi Y; Wang M; Chen Z; Pei Z; Ma W
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):14-6. PubMed ID: 11831976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
    Hutchinson WL; Johnson PJ; Du MQ; Williams R
    Clin Sci (Lond); 1991 Aug; 81(2):177-82. PubMed ID: 1716188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical diagnosis of gangliosidosis GM1].
    Tsvetkova IV; Kozina AB; Rozenfel'd EL; Osipova GN
    Vopr Med Khim; 1978; 24(4):566-9. PubMed ID: 98915
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of serum alkaline phosphatase in secondary hepatic localizations (author's transl)].
    Berizzi GF; Prestipino F; Malacarne Z
    Chir Ital; 1980 Oct; 32(5):1236-41. PubMed ID: 7249182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence.
    Fernández-Rodríguez J; Ayude D; de la Cadena MP; Martínez-Zorzano VS; de Carlos A; Caride-Castro A; de Castro G; Rodríguez-Berrocal FJ
    Cancer Detect Prev; 2000; 24(2):143-9. PubMed ID: 10917134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer.
    Ayude D; Fernández-Rodríguez J; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; de Carlos A; Gil E; Páez de La Cadena M
    Oncology; 2000 Nov; 59(4):310-6. PubMed ID: 11096343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies of primary hepatic carcinoma].
    Iwamura K
    Z Gastroenterol; 1971; 9(8):570-8. PubMed ID: 4341286
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma.
    Leray G; Deugnier Y; Jouanolle AM; Lehry D; Bretagne JF; Campion JP; Brissot P; Le Treut A
    Hepatology; 1989 Feb; 9(2):249-52. PubMed ID: 2536349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.